TabletsTablets
Schedule H (Prescription Required)Antiviral FormulationsCode: 2694

Inosine Pranobex Tablets 500 mg

Generic Formulation:Inosine Pranobex Tablets 500 mg
Pack Size:10's
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹271.88
Brand Estimate*
₹280
Estimated Savings:₹8.12 (3% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Inosine Pranobex (Methisoprinol) is an antiviral and immunomodulating drug combining inosine and a salt of 4-acetamidobenzoic acid and N,N-dimethylamino-2-propanol. It stimulates host cell-mediated immune responses (enhancing T-cell proliferation, NK cell activity, and IL-1/IL-2 cytokine production) while suppressing viral RNA translation. Indicated for mucocutaneous herpes simplex, subacute sclerosing panencephalitis (SSPE), viral respiratory tract infections, and genital warts (HPV).

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 2694.Report inaccuracy

Usage Guidelines

Take orally with water, divided into 3 to 4 doses throughout the day, preferably after meals. Complete the duration prescribed by your doctor.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Transient elevation of serum and urinary uric acid, nausea, vomiting, epigastric discomfort, headache, fatigue. Rare/Severe: Gout flares, arthralgia, and allergic skin eruptions.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Use with caution in patients with history of gout, hyperuricemia, urolithiasis, or impaired renal function. Monitor serum uric acid levels during prolonged therapy.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.